🇺🇸 FDA
Patent

US 8802695

Apoptosis signal-regulating kinase 1 inhibitors

granted A61PA61P1/00A61P1/02

Quick answer

US patent 8802695 (Apoptosis signal-regulating kinase 1 inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61P, A61P1/00, A61P1/02, A61P1/04, A61P1/16